- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Florida Hospital Cancer Institute
I alt 4020 resultater
-
Peking University Cancer Hospital & InstituteUkendtNeoplasmer i leverenKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinale neoplasmerKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtLymfom, stor B-celle, diffusKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinal stromal tumorKina
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma Metastase | Immunterapi | GenekspressionsprofileringKina
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinale neoplasmerKina
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma MetastaseKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMelanom | Metastatisk melanom | Slimhinde melanomKina
-
Shandong Cancer Hospital and InstituteRekrutteringSpiserørskræft | Epigallocatechin Gallate | Dysfagi, esophagealKina
-
Peking University Cancer Hospital & InstituteRekrutteringRecidiverende/refraktær B-celle non-Hodgkin lymfomKina
-
Shandong Cancer Hospital and InstituteRekrutteringNeoadjuverende terapi | Resecerbart ikke-småcellet lungekarcinom | IMMUNOTERAPI | Biomarkører / BlodKina
-
Peking University Cancer Hospital & InstituteRekrutteringKræft i fordøjelsessystemetKina
-
Shandong Cancer Hospital and InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMetastatisk kastrationsresistent prostatakræft
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringFase 2-undersøgelse af SBRT Plus Tislelizumab og Regorafenib i uoperabelt eller oligometastatisk HCCIkke-operabelt hepatocellulært karcinom | Oligometastatisk sygdomKina
-
Peking University Cancer Hospital & InstituteRekrutteringKolorektal cancer | LungekræftKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-småcellet lungekræft | Konsoliderende immunterapi | Strålebehandling eller sekventiel kemoradiationKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuCOVID-19 | Kirurgi-komplikationerKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuBlødt vævssarkom
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Temozolomid | Apatinib | Camrelizumab | Akralt melanom | Neoadjuvans | Patologisk responsKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekrutteringAvanceret melanomKina
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Lungekræft | PD-L1 | PET/CTKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering
-
Shandong Cancer Hospital and InstituteRekruttering
-
Shandong Cancer Hospital and InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringKolorektal cancer | Positron-emissionstomografi | Tumor, fastKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuKolorektal cancer | Radiofrekvensablation | Levermetastase | KRAS Gene | Sikker margin
-
Peking University Cancer Hospital & InstituteRekruttering
-
Shandong Cancer Hospital and InstituteRekruttering
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringSlimhinde melanomKina
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnuMetastatisk brystkræft
-
Peking University Cancer Hospital & InstituteRekruttering